European financial district at dusk
Avertis Group — Capital Advisory

Capital Advisory For Companies At An Inflection Point

Avertis Group advises ambitious FinTech, MedTech, Healthcare and AI companies on institutional capital raises and strategic transactions from Series A onwards.

We work alongside founders, CEOs and management teams to build the investment case, identify the right capital partners and execute the process from investor readiness through transaction.

Get Started
Series A · Series B · Growth Capital · Strategic Transactions
01 — Why Avertis

Built For The Capital Decisions That Define What Comes Next

If you are raising right now, the hard part is rarely finding investor names. It is having a case investors believe, a shortlist worth their time, and someone who keeps the process moving. That is the work we do with you, from preparation to signed round.

Investor Perspective

We look at your company the way investors will, and tell you what needs to be stronger before you go out.

Precision Over Volume

We approach the investors who actually fit your stage, sector and ticket size — not a mass mailing.

Execution Alongside Management

We stay in the process with you: investor meetings, due diligence and the steps to close.

Why Avertis
02 — Capital Advisory

How A Raise Runs With Us

Four steps, one team, from first plan to signed round.

01

Plan The Raise

We agree how much you need, from whom, and by when — before anyone goes to market.

02

Get You Ready

Equity story, deck, model and data room brought to the standard investors expect.

03

Run The Process

We build the investor shortlist, open the doors and keep meetings and follow-ups moving.

04

Close The Round

We stay in it through diligence, terms and signing — and afterwards if you want us to.

Explore Advisory
03 — Our Sectors

Deep Focus Where Capital, Technology And Structural Growth Converge

Coverage is deliberately narrow. We advise where specialist understanding and investor relevance matter most.

01

FinTech

Payments, financial infrastructure, WealthTech, InsurTech, RegTech, embedded finance and emerging financial platforms.

02

MedTech

Medical devices, diagnostics, digital medical technology, clinical technology and healthcare innovation.

03

Healthcare

Digital health, healthcare services, healthcare infrastructure, life sciences and technology-enabled care.

04

Artificial Intelligence

Applied AI, enterprise AI, vertical AI, infrastructure and technology businesses transforming established industries.

Explore Sectors
04 — Our Approach

A Disciplined Capital Process

Six stages, run in sequence and revisited as the transaction develops.

01
Assess

Understand the company, capital requirement, transaction objective and existing investor readiness.

02
Position

Build an institutional investment proposition around strategy, market opportunity, traction and growth.

03
Target

Identify and prioritise investors according to mandate, stage, geography, ticket size and strategic fit.

04
Engage

Run targeted investor engagement and manage relevant conversations.

05
Execute

Support management throughout meetings, diligence, negotiations and transaction progression.

06
Continue

Where useful, remain as an external capital advisory partner beyond the transaction.

05 — Who We Work With

Built For Institutional Ambition

We advise a focused group of companies. The clearer the fit, the more value a mandate creates.

Mandate profile
Stage
Series A through growth and pre-exit
Ticket size
€5M and above
Sectors
FinTech · MedTech · Healthcare · AI
Profile
Venture-backed, institutionally governed
Geography
Europe, with cross-border ambition

Fit is not a filter we apply at the end. It is the first question we answer.

The moment to engage
01
A round is on the horizon

You expect to raise within the next 6–18 months and want the process led properly from the start.

02
A process is already live

The round is underway and investor coverage, positioning or momentum needs strengthening.

03
Readiness is the gap

The business is strong; the equity story, data room and financials are not yet institutional.

04
A strategic decision is near

Series B or C, growth capital, strategic investment, M&A or an exit is being considered.

Institutional architecture
06 — Our Mandate Philosophy

We Do Not Take Every Mandate

Avertis maintains a focused mandate portfolio.

Before accepting an engagement, we assess the company, management team, investment proposition, capital requirement, transaction readiness and probability of execution.

We accept mandates where we believe our involvement can create meaningful value and where expectations between Avertis and management are aligned.

Selectivity protects both our clients and our investor relationships.

07 — Avertis Group

Built For Long-Term Capital Partnerships

Our model is designed around focused mandates, direct senior involvement and long-term alignment with management. We measure our work by the relevance of the capital engaged, the quality of investor conversations created and the progress achieved toward the client’s strategic objective.

01
Focused Mandates
02
Senior Involvement
03
International Investor Perspective
04
Long-Term Alignment
08 — Insights

Capital Intelligence

Perspectives on institutional fundraising, investor readiness, private capital and strategic transactions across our core sectors.

Fundraising

Why Series B Preparation Should Begin Before The Raise

Investor Readiness

What Institutional Investors Evaluate Beyond The Pitch Deck

Capital Markets

How To Build The Right Investor Universe For A Growth Financing

View All Insights
09 — Start A Conversation

Planning Your Next Capital Move?

If you are preparing for a Series A, Series B, growth financing or strategic transaction, tell us about your company and what you are looking to accomplish.

Get Started
FinTech · MedTech · Healthcare · Artificial Intelligence